DNA hypermethylation and the subsequent inactivation of tumor suppressor genes play a key role in AML pathogenesis, with methylation genes (i.e., DNMT3A, TET2, IDH1/2) being among the most frequently mutated in AML [88]. This evidence concerns the gene IDH1 and acute myeloid leukemia.